TradingView
RocketTickers
Sep 13, 2018 4:25 PM
AbbVie Announces Patient-Reported Outcomes Data from Three Pivot
Long
NYSE:ABBV
1D
AbbVie Inc.
NYSE
Description
⋅
Sep 13, 2018 4:25 PM
ABBV: AbbVie
2018-09-13 06:20:00
AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
Beyond Technical Analysis
More